Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saioa Domingo-Echaburu

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Hazardous Materials|December 4, 2020
Rational use of drugs as a source control measure to fight drug pollutionUnax Lertxundi, Saioa Domingo-Echaburu, Gorka Orive
Environmental Science & Technology|December 21, 2021
Pharmaceutical Simplification: Killing Two Birds with One StoneUnax Lertxundi, Saioa Domingo-Echaburu, Gorka Orive
British Journal of Clinical Pharmacology|March 23, 2022
Environmental risk of pharmaceuticals: Let us look at the whole packageUnax Lertxundi, Saioa Domingo-Echaburu, Gorka Orive
Sustainable Chemistry and Pharmacy|April 26, 2021
Ivermectin & COVID-19: Let's keep a One Health perspectiveSaioa Domingo-Echaburu, Gorka Orive, Unax Lertxundi
International Journal of Psychiatry in Clinical Practice|December 14, 2011
The use of antipsychotics in a medium-long stay psychiatric hospital from 1998 to 2010Unax Lertxundi, Saioa Domingo Echaburu, Rafael Hernandez Palacios
The Science of the Total Environment|May 10, 2023
Safe levels of pharmaceuticals in groundwaterIker Egaña, Saioa Domingo-Echaburu, Gorka Orive, et al.
The International Journal of Pharmacy Practice|December 25, 2024
Directive of the minimum training requirements for pharmacists: a lost opportunity to incorporate One Health into the training of future pharmacists?Saioa Domingo-Echaburu, Zuriñe Abajo, Gorka Orive, et al.
Psychopharmacology Bulletin|October 15, 2016
Antipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe?Unax Lertxundi, Saioa Domingo-Echaburu, Javier Peral, et al.
The Science of the Total Environment|August 2, 2023
Perfluorohexyloctane: Do we really need a PFAS for the treatment of Dry Eye Disease?Camino García-Blasco, Saioa Domingo-Echaburu, Gorka Orive, et al.
The Science of the Total Environment|November 15, 2023
Considering environmental impact of medicines in healthcareCamino García-Blasco, Saioa Domingo-Echaburu, Gorka Orive, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Hazardous Materials|December 4, 2020
Rational use of drugs as a source control measure to fight drug pollutionUnax Lertxundi, Saioa Domingo-Echaburu, Gorka Orive
Environmental Science & Technology|December 21, 2021
Pharmaceutical Simplification: Killing Two Birds with One StoneUnax Lertxundi, Saioa Domingo-Echaburu, Gorka Orive
British Journal of Clinical Pharmacology|March 23, 2022
Environmental risk of pharmaceuticals: Let us look at the whole packageUnax Lertxundi, Saioa Domingo-Echaburu, Gorka Orive
Sustainable Chemistry and Pharmacy|April 26, 2021
Ivermectin & COVID-19: Let's keep a One Health perspectiveSaioa Domingo-Echaburu, Gorka Orive, Unax Lertxundi
International Journal of Psychiatry in Clinical Practice|December 14, 2011
The use of antipsychotics in a medium-long stay psychiatric hospital from 1998 to 2010Unax Lertxundi, Saioa Domingo Echaburu, Rafael Hernandez Palacios
The Science of the Total Environment|May 10, 2023
Safe levels of pharmaceuticals in groundwaterIker Egaña, Saioa Domingo-Echaburu, Gorka Orive, et al.
The International Journal of Pharmacy Practice|December 25, 2024
Directive of the minimum training requirements for pharmacists: a lost opportunity to incorporate One Health into the training of future pharmacists?Saioa Domingo-Echaburu, Zuriñe Abajo, Gorka Orive, et al.
Psychopharmacology Bulletin|October 15, 2016
Antipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe?Unax Lertxundi, Saioa Domingo-Echaburu, Javier Peral, et al.
The Science of the Total Environment|August 2, 2023
Perfluorohexyloctane: Do we really need a PFAS for the treatment of Dry Eye Disease?Camino García-Blasco, Saioa Domingo-Echaburu, Gorka Orive, et al.
The Science of the Total Environment|November 15, 2023
Considering environmental impact of medicines in healthcareCamino García-Blasco, Saioa Domingo-Echaburu, Gorka Orive, et al.
Pageof 5